| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/23/1999 | WO1999027944A9 Prevention and treatment of amyloidogenic disease |
| 09/23/1999 | WO1999017755A3 Medicaments |
| 09/23/1999 | DE19812331A1 New benzo-heterocyclic substituted piperidine derivatives useful as excitatory aminoacid receptor antagonists, used e.g. for treating neurodegenerative diseases |
| 09/23/1999 | CA2324270A1 Hypnotic .beta.-carboline derivatives, process for their preparation and their use as medicinal products |
| 09/23/1999 | CA2324268A1 Aromaheterocyclic derivatives |
| 09/23/1999 | CA2324237A1 Combination of a gaba-a alpha 5 inverse agonist and a nicotinic agonist |
| 09/23/1999 | CA2323896A1 Crystalline form of paroxetine |
| 09/23/1999 | CA2323830A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 09/23/1999 | CA2323783A1 Benzenesulfonamide-derivatives and their use as medicaments |
| 09/23/1999 | CA2323618A1 Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor |
| 09/23/1999 | CA2323439A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2321155A1 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943683A1 Human vanilloid receptor homologue Vanilrep1 |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942981A1 Fibroblast growth factor-13 |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942960A1 Promotion of regeneration of organized tissues |
| 09/22/1999 | EP0942925A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 09/22/1999 | EP0942924A2 METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 09/22/1999 | EP0942923A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 09/22/1999 | EP0942910A1 1,4-diazabicyclo[2.2.2]oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942751A1 Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter |
| 09/22/1999 | EP0942748A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
| 09/22/1999 | EP0942735A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders |
| 09/22/1999 | EP0942734A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders |
| 09/22/1999 | EP0942733A1 Use of nk-1 receptor antagonists for treating cognitive disorders |
| 09/22/1999 | EP0942732A1 Use of nk-1 receptor antagonists for treating movement disorders |
| 09/22/1999 | EP0942731A1 Use of nk-1 receptor antagonists for treating substance use disorders |
| 09/22/1999 | EP0942730A1 Use of nk-1 receptor antagonists for treating bipolar disorders |
| 09/22/1999 | EP0942729A1 Use of nk-1 receptor antagonists for treating stress disorders |
| 09/22/1999 | EP0942726A2 Use of aminopiperazine derivatives |
| 09/22/1999 | EP0942723A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 09/22/1999 | EP0942722A1 Tetrahydro-beta-carboline compounds |
| 09/22/1999 | EP0772615B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229408A Dihydroindole derivatives useful as 5-HT-2C receptor antagonists |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1045206C Method for preparing cyclic amide derivative |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955507 Therapeutic substituted guanidines |
| 09/21/1999 | US5955499 Phenylalkylaminoalcohol carbamates and process for preparing the same |
| 09/21/1999 | US5955495 Method of treating diseases of the CNS |
| 09/21/1999 | US5955493 Thiamorphinans with neuroprotective activity |
| 09/21/1999 | US5955485 2,3-dihydro-imidazo(2,1-b)benzothiazole derivatives |
| 09/21/1999 | US5955482 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments |
| 09/21/1999 | US5955479 Levobupivacaine for managing chronic pain |
| 09/21/1999 | US5955475 Salt formation to anhydrate; vacuum evaporation of solvent; water solubility |
| 09/21/1999 | US5955474 Antiedema agents or diuretic antagonist |
| 09/21/1999 | US5955462 Antiinflammatory agents for neurogenic inflammation and administering bisindole or compounds |
| 09/21/1999 | US5955461 Quinoxalinedione derivatives, their production and use in pharmaceutical agents |
| 09/21/1999 | US5955455 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 09/21/1999 | US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955284 Screening for serine protease inhibitors by using; hybridization detecting complex |
| 09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
| 09/21/1999 | US5955104 Multiple unit oral pharmaceutical formulations |
| 09/21/1999 | US5955089 Streptococcus for vaccines |
| 09/21/1999 | CA2192975C Benzimidazolone derivatives |
| 09/21/1999 | CA2174971C Neural axon outgrowth modulators |
| 09/21/1999 | CA2135751C 4-mercaptoacetylamino-¬2| benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 09/21/1999 | CA2127253C Composition to help stop smoking |
| 09/21/1999 | CA2006087C Polypeptides isolated from the venom of the spider hololena curta |
| 09/16/1999 | WO1999046381A2 Human fgf gene and gene expression products |
| 09/16/1999 | WO1999046367A2 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046259A1 5-heteroaryl substituted indoles |
| 09/16/1999 | WO1999046254A2 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis |
| 09/16/1999 | WO1999046253A1 Heterocyclyl anthracyclinone derivatives |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046245A2 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
| 09/16/1999 | WO1999046242A1 Cycloalkene derivatives, process for producing the same, and use |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999045952A2 Method of preventing the death of retinal neurons and treating ocular diseases |
| 09/16/1999 | WO1999045949A2 Use of follistatin to modulate gdf-8 and bmp-11 |
| 09/16/1999 | WO1999045947A1 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 09/16/1999 | WO1999045931A1 Epiallopregnanolone in the treatment of cns disorders |
| 09/16/1999 | WO1999045925A1 Novel opiate compounds, methods of making and methods of use |
| 09/16/1999 | WO1999045924A1 Composition |
| 09/16/1999 | WO1999045918A1 Methods and compositions for delivery of taxanes |
| 09/16/1999 | WO1999045907A2 Metal chelators for use in the treatment of alzheimer's disease |
| 09/16/1999 | WO1999034785A3 Treatment of dyskinesias |
| 09/16/1999 | WO1999015684A9 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 09/16/1999 | WO1999015657A3 53bp2 complexes |
| 09/16/1999 | WO1998017230A3 New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives |
| 09/16/1999 | CA2683097A1 Novel opiate compounds, methods of making and methods of use |
| 09/16/1999 | CA2601285A1 Agents for use in the treatment of amyloidosis |
| 09/16/1999 | CA2587736A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323177A1 Composition |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |